These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16741933)

  • 21. Evidence that COMT genotype and proline interact on negative-symptom outcomes in schizophrenia and bipolar disorder.
    Clelland CL; Drouet V; Rilett KC; Smeed JA; Nadrich RH; Rajparia A; Read LL; Clelland JD
    Transl Psychiatry; 2016 Sep; 6(9):e891. PubMed ID: 27622935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
    Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
    Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia.
    Liao SY; Lin SH; Liu CM; Hsieh MH; Hwang TJ; Liu SK; Guo SC; Hwu HG; Chen WJ
    Genes Brain Behav; 2009 Mar; 8(2):228-37. PubMed ID: 19077118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives.
    Lelli-Chiesa G; Kempton MJ; Jogia J; Tatarelli R; Girardi P; Powell J; Collier DA; Frangou S
    Psychol Med; 2011 Apr; 41(4):779-88. PubMed ID: 20667170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test.
    Opgen-Rhein C; Neuhaus AH; Urbanek C; Hahn E; Sander T; Dettling M
    Schizophr Bull; 2008 Nov; 34(6):1231-9. PubMed ID: 18199630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives.
    Lopez-Garcia P; Cristobal-Huerta A; Young Espinoza L; Molero P; Ortuño Sanchez-Pedreño F; Hernández-Tamames JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():176-82. PubMed ID: 27421706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients.
    Zumárraga M; Dávila R; Basterreche N; Arrue A; Goienetxea B; Zamalloa MI; Erkoreka L; Bustamante S; Inchausti L; González-Torres MA; Guimón J
    Neurochem Int; 2010; 56(6-7):774-9. PubMed ID: 20206656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMT: a common susceptibility gene in bipolar disorder and schizophrenia.
    Shifman S; Bronstein M; Sternfeld M; Pisanté A; Weizman A; Reznik I; Spivak B; Grisaru N; Karp L; Schiffer R; Kotler M; Strous RD; Swartz-Vanetik M; Knobler HY; Shinar E; Yakir B; Zak NB; Darvasi A
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):61-4. PubMed ID: 15211633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
    Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
    Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.
    Zalla T; Joyce C; Szöke A; Schürhoff F; Pillon B; Komano O; Perez-Diaz F; Bellivier F; Alter C; Dubois B; Rouillon F; Houde O; Leboyer M
    Psychiatry Res; 2004 Jan; 121(3):207-17. PubMed ID: 14675740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
    Wang H; Zhang B; Zeng B; Tang Y; Zhang T; Zhao S; Li C; Wang J; Goff DC
    Schizophr Res; 2018 Sep; 199():214-220. PubMed ID: 29730044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
    Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ
    Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.
    Miskowiak KW; Kjaerstad HL; Støttrup MM; Svendsen AM; Demant KM; Hoeffding LK; Werge TM; Burdick KE; Domschke K; Carvalho AF; Vieta E; Vinberg M; Kessing LV; Siebner HR; Macoveanu J
    Bipolar Disord; 2017 May; 19(3):214-224. PubMed ID: 28544426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and disorder-specific aspects of resting state EEG abnormalities in schizophrenia.
    Venables NC; Bernat EM; Sponheim SR
    Schizophr Bull; 2009 Jul; 35(4):826-39. PubMed ID: 18381357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
    Bilder RM; Volavka J; Czobor P; Malhotra AK; Kennedy JL; Ni X; Goldman RS; Hoptman MJ; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Kunz M; Chakos M; Cooper TB; Lieberman JA
    Biol Psychiatry; 2002 Oct; 52(7):701-7. PubMed ID: 12372660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls.
    Matsuzaka CT; Christofolini D; Ota VK; Gadelha A; Berberian AA; Noto C; Mazzotti DR; Spindola LM; Moretti PN; Smith MAC; Melaragno MI; Belangero SI; Bressan RA
    Braz J Psychiatry; 2017; 39(4):302-308. PubMed ID: 28273278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder.
    Rotondo A; Mazzanti C; Dell'Osso L; Rucci P; Sullivan P; Bouanani S; Gonnelli C; Goldman D; Cassano GB
    Am J Psychiatry; 2002 Jan; 159(1):23-9. PubMed ID: 11772685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.
    Alfimova MV; Golimbet VE; Gritsenko IK; Lezheiko TV; Abramova LI; Strel'tsova MA; Khlopina IV; Ebstein R
    Neurosci Behav Physiol; 2007 Sep; 37(7):643-50. PubMed ID: 17763983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele.
    Schürhoff F; Szöke A; Chevalier F; Roy I; Méary A; Bellivier F; Giros B; Leboyer M
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):64-8. PubMed ID: 17034018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.